Skip to content
2000
Volume 12, Issue 3
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

The United States Food and Drug Administration currently states that the use of stimulants in patients with tic disorders and/or family history of tic disorders including Tourette’s syndrome is contraindicated. Patients with attention deficit hyperactivity disorder (ADHD), however, are at increased risk of tics regardless of stimulants use. After evaluating the most recent literature on the incidence of tic disorders in pediatric patients treated with stimulants for ADHD, it is reasonable to say that the incidence of tics and the severity of tics are not increased by the use of these medications. For patients with pre-existing tic disorders, the usual recommended dosing of stimulants should be used because supratherapeutic doses of this class of medications, specifically dextroamphetamine, have shown to exacerbate tic disorders.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/1573396312666160728113443
2016-08-01
2025-09-15
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/1573396312666160728113443
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test